Daniel E. Pleguezuelo

1.4k total citations
25 papers, 471 citations indexed

About

Daniel E. Pleguezuelo is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Daniel E. Pleguezuelo has authored 25 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 11 papers in Hematology and 11 papers in Immunology. Recurrent topics in Daniel E. Pleguezuelo's work include Systemic Lupus Erythematosus Research (11 papers), Platelet Disorders and Treatments (9 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Daniel E. Pleguezuelo is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Platelet Disorders and Treatments (9 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Daniel E. Pleguezuelo collaborates with scholars based in Spain and Israel. Daniel E. Pleguezuelo's co-authors include Óscar Cabrera-Marante, Antonio Serrano, Estela Paz‐Artal, Francisco Javier Gil‐Etayo, Laura Naranjo, Luís M. Allende, Antonio Lalueza, Raquel Díaz‐Simón, Manuel Serrano and Daniel Arroyo‐Sánchez and has published in prestigious journals such as Circulation, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Daniel E. Pleguezuelo

21 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Pleguezuelo Spain 14 187 178 141 86 85 25 471
Óscar Cabrera-Marante Spain 14 308 1.6× 181 1.0× 130 0.9× 87 1.0× 81 1.0× 26 582
Ruth Fernandez‐Ruiz United States 11 106 0.6× 251 1.4× 295 2.1× 31 0.4× 24 0.3× 22 545
Sira Nanthapisal Thailand 13 115 0.6× 236 1.3× 100 0.7× 53 0.6× 65 0.8× 36 562
Pieter van der Pol Netherlands 15 136 0.7× 295 1.7× 43 0.3× 23 0.3× 81 1.0× 25 616
V. Veit France 14 63 0.3× 113 0.6× 208 1.5× 33 0.4× 142 1.7× 40 606
Albert Holvast Netherlands 8 106 0.6× 263 1.5× 256 1.8× 31 0.4× 72 0.8× 9 554
Cristina Garufi Italy 12 46 0.2× 114 0.6× 247 1.8× 25 0.3× 82 1.0× 46 393
K. Mazodier France 12 229 1.2× 275 1.5× 100 0.7× 47 0.5× 307 3.6× 37 743
R.L. Dawkins Australia 16 51 0.3× 297 1.7× 102 0.7× 65 0.8× 74 0.9× 37 579
Anna Zanetti Italy 12 52 0.3× 132 0.7× 250 1.8× 28 0.3× 117 1.4× 36 399

Countries citing papers authored by Daniel E. Pleguezuelo

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Pleguezuelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Pleguezuelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Pleguezuelo more than expected).

Fields of papers citing papers by Daniel E. Pleguezuelo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Pleguezuelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Pleguezuelo. The network helps show where Daniel E. Pleguezuelo may publish in the future.

Co-authorship network of co-authors of Daniel E. Pleguezuelo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Pleguezuelo. A scholar is included among the top collaborators of Daniel E. Pleguezuelo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Pleguezuelo. Daniel E. Pleguezuelo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabrera-Marante, Óscar, Daniel E. Pleguezuelo, Laura Naranjo, et al.. (2025). Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome. Frontiers in Immunology. 16. 1636171–1636171.
2.
Paz‐Artal, Estela, et al.. (2025). Malignancy and Autoimmune Susceptibility in Adult Patients with Human Inborn Errors of Immunity. Journal of Clinical Immunology. 45(1). 136–136.
3.
Lalueza, Antonio, Francisco Javier Gil‐Etayo, Raquel Díaz‐Simón, et al.. (2024). Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis. Frontiers in Immunology. 15. 1443096–1443096. 2 indexed citations
4.
Cabrera-Marante, Óscar, Daniel E. Pleguezuelo, Francisco Javier Gil‐Etayo, et al.. (2023). Quantification of Antiphospholipid Antibodies: The Importance of Using an Appropriate Methodology for Each Clinical Profile. International Journal of Molecular Sciences. 24(24). 17373–17373. 2 indexed citations
5.
Gil‐Etayo, Francisco Javier, Alberto Utrero‐Rico, Óscar Cabrera-Marante, et al.. (2022). An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution. Biomedicines. 10(2). 296–296. 23 indexed citations
6.
Gil‐Etayo, Francisco Javier, Esther Mancebo, Antonio Lalueza, et al.. (2022). Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution. International Journal of Molecular Sciences. 23(12). 6577–6577. 4 indexed citations
7.
Pleguezuelo, Daniel E., Óscar Cabrera-Marante, Laura Naranjo, et al.. (2021). Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss. Journal of Clinical Medicine. 10(10). 2094–2094. 17 indexed citations
8.
Lalueza, Antonio, Hernando Trujillo, María Dolores Folgueira, et al.. (2021). Influenza A-Associated In-Hospital Mortality in Very Older People: Does Inflammation Also Play a Role?. Gerontology. 68(7). 780–788. 3 indexed citations
9.
Gil‐Etayo, Francisco Javier, Antonio Lalueza, Raquel Díaz‐Simón, et al.. (2021). Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines. 9(8). 899–899. 17 indexed citations
10.
Arroyo‐Sánchez, Daniel, Óscar Cabrera-Marante, Patricia Almendro-Vázquez, et al.. (2021). Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency. Journal of Clinical Immunology. 42(2). 240–252. 33 indexed citations
11.
González‐Granado, Luis Ignacio, Raquel Ruiz‐García, Daniel E. Pleguezuelo, et al.. (2021). Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. Frontiers in Immunology. 12. 671755–671755. 49 indexed citations
12.
Naranjo, Laura, Fernando Ostos, Francisco Javier Gil‐Etayo, et al.. (2021). Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke. Frontiers in Cardiovascular Medicine. 8. 665741–665741. 17 indexed citations
13.
Pleguezuelo, Daniel E., Raquel Díaz‐Simón, Óscar Cabrera-Marante, et al.. (2021). Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome. Frontiers in Immunology. 12. 667515–667515. 20 indexed citations
14.
Gil‐Etayo, Francisco Javier, Óscar Cabrera-Marante, Daniel Arroyo‐Sánchez, et al.. (2021). T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression. Frontiers in Cellular and Infection Microbiology. 11. 624483–624483. 115 indexed citations
15.
Cabrera-Marante, Óscar, Manuel Serrano, Fernando Lozano, et al.. (2020). The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome. International Journal of Molecular Sciences. 21(23). 8972–8972. 23 indexed citations
16.
Cabrera-Marante, Óscar, Daniel E. Pleguezuelo, Luís M. Allende, et al.. (2020). Perforin gene variant A91V in young patients with severe COVID-19.. Haematologica. 105(12). 2844–2846. 14 indexed citations
17.
Serrano, Manuel, José A. Martínez-Flores, Esther Mancebo, et al.. (2019). Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation. Frontiers in Immunology. 10. 2891–2891. 7 indexed citations
18.
Molina, María, Luis M. Allende, Eduardo Gutiérrez, et al.. (2018). CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients. Frontiers in Immunology. 9. 1221–1221. 28 indexed citations
19.
Cabrera-Marante, Óscar, Manuel Serrano, José A. Martínez-Flores, et al.. (2017). Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies. PLoS ONE. 12(7). e0178889–e0178889. 33 indexed citations
20.
Pleguezuelo, Daniel E. & Silvia Sánchez‐Ramón. (2016). Nuevas posibilidades de tratamiento con inmunoglobulinas subcutáneas. Medicina Clínica. 148(2). 86–90.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Óscar Cabrera-Marante Breakdown of academic impact, for papers by Ruth Fernandez‐Ruiz Breakdown of academic impact, for papers by Sira Nanthapisal Breakdown of academic impact, for papers by Pieter van der Pol Breakdown of academic impact, for papers by V. Veit Breakdown of academic impact, for papers by Albert Holvast Breakdown of academic impact, for papers by Cristina Garufi Breakdown of academic impact, for papers by K. Mazodier Breakdown of academic impact, for papers by R.L. Dawkins Breakdown of academic impact, for papers by Anna Zanetti
Rankless by CCL
2026